7. Wierenga RK, Kapetaniou EG, Venkatesan R. Triosephosphate isomerase: a highly evolved biocatalyst. Cellular and Molecular Life Sciences. 2010 August 7 67:3961-3982. PMID: 20694739 [1]
Human triosephosphate isomerase complex with phosphoglycolic acid 1hti
Triose phosphate isomerase (TIM)[1][2] (PDB 1wyi and 1hti) is a crucial enzyme in the glycolytic pathway. TIM reversibly converts the aldose Glyceraldehyde-3-phosphate (GAP) to the ketose Dihydroxyacetone phosphate (DHAP). The interconversion proceeds by an enediol intermediate. Triose phosphate isomerase is not directly regulated, but the enzyme two steps before it in the glycolytic pathway, phosphofructokinase, is a heavily regulated, irreversible enzyme.
Structural Characteristics
The secondary structure consists of 14 alpha helices and 8 beta sheets per monomer, making it fall in the SCOP category of alpha and beta proteins. The tertiary structure is a alpha-beta barrel, and it is the prototypical example of the "TIM barrel" fold (see ribbon drawing).
The quaternary structure is a homodimer. The molecular weight of the enzyme is estimated at 57,400 Da.[3]
Mechanism of Triose phosphate isomerase. Created by Christian Krenk using Spartan 08.
An interesting part of the enzyme is the flexible loop that stabilizes the enediol-like transition state. The flexible loop (residues 167-176)[6] closes over the active site like a hinged lid when substrate is bound, thus preventing phosphate from leaving. A four-residue segment of the loop H-bonds with the phosphate group of the substrate.[4] Without the loop, the enediol intermediate would eliminate phosphate, with the end products being inorganic phosphate and toxic methylglyoxal.[4]
↑Kinoshita T, Maruki R, Warizaya M, Nakajima H, Nishimura S. Structure of a high-resolution crystal form of human triosephosphate isomerase: improvement of crystals using the gel-tube method. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Apr 1;61(Pt, 4):346-9. Epub 2005 Mar 24. PMID:16511037 doi:10.1107/S1744309105008341
↑Mande SC, Mainfroid V, Kalk KH, Goraj K, Martial JA, Hol WG. Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci. 1994 May;3(5):810-21. PMID:8061610
↑ 3.03.1Dabrowska A, Kamrowska I, Baranowski T. Purification, crystallization and properties of triosephosphate isomerase from human skeletal muscle. Acta Biochim Pol. 1978;25(3):247-56. PMID:752201
↑ 4.04.14.2Voet, Donald, Judith G. Voet, and Charlotte W. Pratt. Fundamentals of Biochemistry Life at the Molecular Level. New York: John Wiley & Sons, 2008. p. 495. Print.
↑ 5.05.1Lodi PJ, Chang LC, Knowles JR, Komives EA. Triosephosphate isomerase requires a positively charged active site: the role of lysine-12. Biochemistry. 1994 Mar 15;33(10):2809-14. PMID:8130193
↑Lolis E, Petsko GA. Crystallographic analysis of the complex between triosephosphate isomerase and 2-phosphoglycolate at 2.5-A resolution: implications for catalysis. Biochemistry. 1990 Jul 17;29(28):6619-25. PMID:2204418
References
↑Wierenga RK, Kapetaniou EG, Venkatesan R. Triosephosphate isomerase: a highly evolved biocatalyst. Cell Mol Life Sci. 2010 Dec;67(23):3961-82. Epub 2010 Aug 7. PMID:20694739 doi:10.1007/s00018-010-0473-9
Proteopedia Page Contributors and Editors (what is this?)